TVTX — TRAVERE THERAPEUTICS INC

Ownership history in INCEPTIONR LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which INCEPTIONR LLC reported a position in TRAVERE THERAPEUTICS INC (TVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2025 Q3)
Avg. % of fund
0.06%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 10,487 — — 0.06% $251K $23.90
% of Fund (quarterly)    TVTX price (monthly, adj. close)

Other funds also holding TVTX

As of 2025 Q4 — sorted by position size

Rock Springs Capital Management LP 3Y 7Y 4.33% Knott David M Jr 3Y 3.29% PERCEPTIVE ADVISORS LLC 3Y 7Y 2.91% Eversept Partners, LP 3Y 7Y 2.26% EMERALD ADVISERS, LLC 3Y 7Y 1.88% ARMISTICE CAPITAL, LLC 3Y 7Y 1.71% Exome Asset Management LLC 1.63% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 1.32% Kynam Capital Management, LP 3Y 1.26% Lisanti Capital Growth, LLC 3Y 7Y 1.25%
← Back to INCEPTIONR LLC Holdings